Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Stockholders' Equity

v3.25.4
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Private Placement Warrants
Public Warrants
At-The-Market Public Offering
Underwritten Public Offering
Private Placement
Common Stock
Common Stock
Private Placement Warrants
Common Stock
Public Warrants
Common Stock
At-The-Market Public Offering
Common Stock
Underwritten Public Offering
Common Stock
Private Placement
Additional Paid-In Capital
Additional Paid-In Capital
Private Placement Warrants
Additional Paid-In Capital
Public Warrants
Additional Paid-In Capital
At-The-Market Public Offering
Additional Paid-In Capital
Underwritten Public Offering
Additional Paid-In Capital
Private Placement
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning balance (In shares) at Dec. 31, 2022             622,602,815                          
Beginning balance at Dec. 31, 2022 $ 1,164,741           $ 61           $ 1,908,179           $ (734,653) $ (8,846)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                        
Net loss (513,050)                                   (513,050)  
Other comprehensive loss 8,366                                     8,366
Issuance of common stock upon exercise of stock options (in shares)             2,923,022                          
Issuance of common stock upon exercise of stock options 1,910           $ 3           1,907              
Issuance of common stock upon vesting of restricted stock units (in shares)             11,694,630                          
Issuance of common stock in private placement (in shares)             59,160,449                          
Issuance of common stock in private placement 279,899           $ 6           279,893              
Issuance of common stock under Employee Stock Purchase Plan (in shares)             1,881,109                          
Issuance of common stock under Employee Stock Purchase Plan 6,918                       6,918              
Vesting of early exercised stock options and common stock issued in private placement 523                       523              
Stock-based compensation 85,055                       85,055              
Ending balance (In shares) at Dec. 31, 2023             698,262,025                          
Ending balance at Dec. 31, 2023 1,034,362           $ 70           2,282,475           (1,247,703) (480)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                        
Net loss (608,034)                                   (608,034)  
Other comprehensive loss (103)                                     (103)
Issuance of common stock upon exercise of stock options (in shares)             3,367,232                          
Issuance of common stock upon exercise of stock options 1,475           $ 1           1,474              
Issuance of common stock upon vesting of restricted stock units (in shares)             14,467,566                          
Issuance of common stock in private placement (in shares)                   16,158,784 46,000,000                  
Issuance of common stock in private placement       $ 128,836 $ 221,854         $ 2 $ 5         $ 128,834 $ 221,849      
Issuance of common stock under Employee Stock Purchase Plan (in shares)             2,600,522                          
Issuance of common stock under Employee Stock Purchase Plan 11,200                       11,200              
Vesting of early exercised stock options and common stock issued in private placement 424                       424              
Issuance of common stock in acquisition (in shares)             3,320,235                          
Issuance of common stock in acquisition 9,472                       9,472              
Stock-based compensation $ 112,877                       112,877              
Ending balance (In shares) at Dec. 31, 2024 784,176,364           784,176,364                          
Ending balance at Dec. 31, 2024 $ 912,363           $ 78           2,768,605           (1,855,737) (583)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                        
Net loss (929,842)                                   (929,842)  
Other comprehensive loss $ 2,100                                     2,100
Issuance of common stock upon exercise of stock options (in shares) 3,379,622           3,360,948                          
Issuance of common stock upon exercise of stock options $ 2,801           $ 2           2,799              
Issuance of common stock upon vesting of restricted stock units (in shares)             14,199,687                          
Issuance of common stock in private placement (in shares)                   13,792,015 35,075,000 49,701,790                
Issuance of common stock in private placement       $ 153,567 $ 575,935 $ 290,163       $ 1 $ 4 $ 5       $ 153,566 $ 575,931 $ 290,158    
Issuance of common stock under Employee Stock Purchase Plan (in shares)             2,308,333                          
Issuance of common stock under Employee Stock Purchase Plan 12,073                       12,073              
Issuance of common stock upon exercise of warrants (in shares)               4,128,197 3,008,779                      
Issuance of common stock upon exercise of warrants   $ 70,468 $ 60,696                     $ 70,468 $ 60,696          
Vesting of earnout shares 60,709                       60,709              
Issuance of common stock in acquisition (in shares)             5,325,585                          
Issuance of common stock in acquisition 76,203           $ 1           76,202              
Stock-based compensation $ 122,477                       122,477              
Ending balance (In shares) at Dec. 31, 2025 915,076,698           915,076,698                          
Ending balance at Dec. 31, 2025 $ 1,409,713           $ 91           $ 4,193,684           $ (2,785,579) $ 1,517